1.Synthesis of precursor of anti-inflammatory agents by using highly reactive zinc.
Aishah AJ ; Nobuhito K ; Tokuda M
The Medical Journal of Malaysia 2004;59 Suppl B():210-211
Highly reactive zinc metal was prepared by electrolysis of a N,N-dimethylformamide (DMF) solution containing naphthalene and a supporting electrolyte in a one-compartment cell fitted with a platinum cathode and a zinc anode. This highly reactive electrogenerated zinc (EGZn/Naph) was used for transformation of ethyl 2-bromoacrylate into the corresponding organozinc compound, which can not be achieved by the use of usual zinc metals. Reaction of the organozinc compounds thus prepared with various aryl halides in the presence of 5 mol% of palladium catalyst gave the corresponding cross-coupling products in high yields. These cross-coupling reactions were successfully applied to a synthesis of the precursor of anti-inflammatory agents such as ibuprofen, naproxen, cicloprofen and suprofen.
Anti-Inflammatory Agents, Non-Steroidal/*chemical synthesis
;
Catalysis
;
Electrolysis
;
Ibuprofen/chemical synthesis
;
Naphthalenes
;
Naproxen/chemical synthesis
;
Prodrugs/*chemical synthesis
;
Propionic Acids/chemical synthesis
;
Suprofen/chemical synthesis
;
Zinc/*pharmacology
2.A novel class of anti-inflammatory and analgesic drugs--NO-donating NSAIDs.
Yi-hua ZHANG ; Hui JI ; Si-xun PENG
Acta Pharmaceutica Sinica 2007;42(4):352-357
Traditional non-steroidal anti-inflammatory drugs (NSAIDs) and COX-2 selective inhibitors are among the most widely used drugs. However, their significant side effects in gastrointestinal and cardiovascular systems limited the use of these drugs. Recently, research and development of NO-donating NSAIDs (NO-NSAIDs) have become one of the most important strategies to reduce these side effects. NO-NSAIDs may exert a broad range of positive effects in terms of NO-mediated gastrointestinal and cardiovascular safety as well as comparable or increased anti-inflammatory, analgesic properties relative to NSAIDs. This review briefly deals with chemistry of NO-NSAIDs, more details are focused on biological significance, mechanism of action, and therapeutic potential of this novel class of drugs.
Acetaminophen
;
analogs & derivatives
;
chemistry
;
pharmacology
;
Animals
;
Anti-Inflammatory Agents, Non-Steroidal
;
adverse effects
;
pharmacology
;
Aspirin
;
analogs & derivatives
;
chemistry
;
pharmacology
;
Cardiotonic Agents
;
pharmacology
;
Cyclooxygenase Inhibitors
;
adverse effects
;
pharmacology
;
Flurbiprofen
;
analogs & derivatives
;
chemistry
;
pharmacology
;
Gastrointestinal Diseases
;
chemically induced
;
prevention & control
;
Humans
;
Ibuprofen
;
analogs & derivatives
;
chemistry
;
pharmacology
;
Naproxen
;
analogs & derivatives
;
chemistry
;
pharmacology
;
Nitrates
;
chemistry
;
pharmacology
;
Nitric Oxide Donors
;
pharmacology
3.Molecular characteristics of the inhibition of human neutrophil elastase by nonsteroidal antiinflammatory drugs.
Kooil KANG ; Sung Jun BAE ; Woo Mi KIM ; Dae Heui LEE ; Un Suck CHO ; Mu Sang LEE ; Myung Huck LEE ; Sang Il NAM ; Klaus E KUETTNER ; David E SCHWARTZ
Experimental & Molecular Medicine 2000;32(3):146-154
Nonsteroidal antiinflammatory drugs(NSAIDs) are known as clinically effective agents for treatment of inflammatory diseases. Inhibition of cyclooxygenase has been thought to be a major facet of the pharmacological mechanism of NSAIDs. However, it is difficult to ascribe the antiinflammatory effects of NSAIDs solely to the inhibition of prostaglandin synthesis. Human neutrophil elastase (HNElastase; HNE, EC 3.4.21.37) has been known as a causative factor in inflammatory diseases. To investigate the specific relationship between HNElastase inhibition and specificity of molecular structure of several NSAIDs, HNElastase was purified by Ultrogel AcA54 gel filtration, CM-Sephadex ion exchange, and HPLC (with TSK 250 column) chromatography. HNElastase was inhibited by aspirin and salicylate in a competitive manner and by naproxen, ketoprofen, phenylbutazone, and oxyphenbutazone in a partial competative manner, but not by ibuprofen and tolmetin. HNElastase-phenylbutazone-complex showed strong Raman shifts at 200, 440, 1124, 1194, 1384, 1506, and 1768 cm(-1). The Raman bands 1194, 1384, and 1768 cm(-1) may represent evidences of the conformational change at -N=N-phi radical, pyrazol ring, and -C=O radical of the elastase-drug complex, respectively. Phenylbutazone might be bound to HNElastase by ionic and hydrophobic interaction, and masked the active site. Inhibition of HNElastase could be another mechanism of action of NSAIDs besides cyclooxygenase inhibition in the treatment of inflammatory diseases. Different inhibition characteristics of HNE-lastase by NSAIDs such as aspirin, phenylbutazone-like drugs and ineffective drugs could be important points for drawing the criteria for appropriate drugs in clinical application.
Anti-Inflammatory Agents, Non-Steroidal/pharmacology*
;
Chromatography, Affinity
;
Computer Simulation
;
Enzyme Inhibitors/pharmacology
;
Human
;
Isoenzymes/isolation & purification
;
Isoenzymes/antagonists & inhibitors
;
Ketoprofen/pharmacology
;
Leukocyte Elastase/isolation & purification
;
Leukocyte Elastase/antagonists & inhibitors*
;
Models, Molecular
;
Naproxen/pharmacology
;
Phenylbutazone/analogs & derivatives
;
Salicylates/pharmacology
;
Spectrum Analysis, Raman